Lv1
38 积分 2022-04-10 加入
Preclinical Development and a Case Report of a Nanobody-Based CLDN18.2 CAR-T IMC002 with Reduced On-Target Off-Tumor Toxicity
1天前
待确认
Potentiating CAR-T cell function in the immunosuppressive tumor microenvironment by inverting the TGF-β signal
3个月前
已完结
Acquired resistance to immunotherapy by physical barriers with cancer cell-expressing collagens in non-small cell lung cancer
5个月前
已完结
Epigenetic Therapies for Cancer
5个月前
已完结
皖公网安备34019202002308
